Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

Thu, 15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday:

----------

FTSE 100

----------

Credit Suisse cuts AstraZeneca to 'neutral' (outperform) - price target 11,000 pence

----------

Credit Suisse raises GSK to 'neutral' (underperform) - price target 1,430 (1,630) pence

----------

Jefferies cuts Hikma Pharmaceutical price target to 2020 (2290) pence - 'buy'

----------

Berenberg cuts Admiral Group price target to 2,819 (2,903) pence - 'buy'

----------

Berenberg raises InterContinental Hotels target to 6,500 (5,700) pence - 'buy'

----------

Barclays cuts Whitbread price target to 3,500 (4,000) pence - 'overweight'

----------

Berenberg cuts Howden Joinery group price target to 620 (780) pence - 'hold'

----------

RBC cuts Dechra Pharma price target to 4,000 (4,200) pence - 'outperform'

----------

HSBC raises BT Group to 'buy' (hold)

----------

FTSE 250

----------

JPMorgan raises Trainline price target to 425 (420) pence - 'neutral'

----------

Berenberg cuts Volution price target to 460 (550) pence - 'buy'

----------

Berenberg cuts Travis Perkins price target to 910 (1,000) pence - 'hold'

----------

Berenberg cuts Marshalls price target to 380 (400) pence - 'hold'

----------

Berenberg cuts Ibstock price target to 180 (210) pence - 'hold'

----------

Berenberg cuts Genuit price target to 470 (530) pence - 'buy'

----------

Berenberg starts Currys with 'hold' - price target 70 pence

----------

Barclays cuts John Wood Group price target to 250 (320) pence - 'overweight'

----------

Barclays cuts C&C Group price target to 230 (240) pence - 'overweight'

----------

Citigroup raises Tate & Lyle to 'buy' (neutral) - price target 850 pence

----------

Goldman Sachs cuts Marks & Spencer price target to 125 (140) pence - 'sell'

----------

Jefferies cuts Redrow price target to 768 (780) pence - 'buy'

----------

SMALL CAP

----------

Morgan Stanley raises AIB target to 3 (2,80) EUR - 'equal-weight'

----------

Morgan Stanley raises Bank of Ireland target to 7,60 (7,40) EUR - 'equal-weight'

----------

Jefferies cuts DFS Furniture price target to 210 (270) pence - 'buy'

----------

Berenberg cuts Eurocell price target to 250 (310) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 300 (310) pence - 'buy'

----------

Berenberg cuts Forterra price target to 250 (270) pence - 'hold'

----------

Berenberg cuts Breedon price target to 80 (100) pence - 'buy'

----------

Goldman Sachs cuts ITM Power price target to 120 (220) pence - 'sell'

----------

HSBC cuts Johnson Service Group to 'hold' (buy)

----------

Bank of America raises Fevertree Drinks price target to 1,030 (950) pence - 'neutral'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Sep 2022 09:23

TOP NEWS: Dechra shares down as post-pandemic growth rates slow

(Alliance News) - Dechra Pharmaceuticals PLC on Monday reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.

Read more
5 Sep 2022 08:48

LONDON MARKET OPEN: Countryside and Vistry sign GBP1.3 billion merger

(Alliance News) - Stocks in London were under pressure at the opening bell on Monday, as the mood turned sour on Friday evening after Russia shut off access to a key gas pipeline.

Read more
5 Sep 2022 07:51

LONDON MARKET BRIEFING: Gazprom's move gets week off to bumpy start

(Alliance News) - Stocks in London are set to kick off the new week on the back foot, as Russia's move to stop gas deliveries to Europe is giving investors pause, amid growing fears of an energy crisis.

Read more
5 Sep 2022 07:01

Dechra Pharmaceuticals FY revenues and profits rise

(Sharecast News) - Veterinary pharmaceuticals group Dechra said on Monday that both revenues and profits had risen throughout the twelve months ended 30 June.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 12:16

LONDON MARKET MIDDAY: Pound weakness props up FTSE 100 as oil fades

(Alliance News) - The FTSE 100 remained in the green on Tuesday at midday on account of a weaker pound, but gains ebbed as oil prices retreated from morning highs.

Read more
30 Aug 2022 08:49

TOP NEWS: Dechra Pharmaceuticals buys US manufacturer Med-Pharmex

(Alliance News) - Dechra Pharmaceuticals PLC on Tuesday said it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex Inc for USD260.0 million.

Read more
30 Aug 2022 07:59

LONDON MARKET PRE-OPEN: Bunzl raises full-year margin outlook

(Alliance News) - Stock trading in London is set for a tepid start as UK market participants return from holiday on Tuesday, catching up with Monday's losses in Europe, as investors continue to mull over hawkish remarks from the head of the US central bank.

Read more
30 Aug 2022 07:53

Dechra Pharmaceuticals buys California-based Med-Pharmex for $260m

(Sharecast News) - Dechra Pharmaceuticals said on Tuesday that it has bought California-based veterinary pharmaceutical manufacturer Med-Pharmex for $260m (£221.5m).

Read more
21 Jul 2022 17:08

LONDON MARKET CLOSE: Stocks rise; ECB supersizes interest rate hike

(Alliance News) - Stocks in London ended higher on Thursday as investors digested another raft of corporate earnings, while the European Central Bank surprised markets with an aggressive rate hike.

Read more
21 Jul 2022 09:26

Dechra raises £180m in discounted placing for Piedmont deal

(Sharecast News) - Dechra Pharmaceuticals slumped on Thursday after the animal drug maker raised around £180m in a discounted share placing for the acquisition of US-based Piedmont Animal Health.

Read more
21 Jul 2022 09:03

LONDON MARKET OPEN: Large-caps down ahead of ECB; Russian gas resumes

(Alliance News) - Large-cap stocks in Europe struggled in early dealings on Thursday, as traders await a policy decision from the European Central Bank and after gas supplies through the critical Nord Stream pipeline restarted.

Read more
21 Jul 2022 08:47

Dechra Pharmaceuticals raises GBP184 million for acquisition pipeline

(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Thursday said it raised GBP184 million in a discounted share placing and subscription for its acquisition pipeline.

Read more
20 Jul 2022 18:34

Dechra to raise GBP180 million to acquire Piedmont Animal Health

(Alliance News) - Veterinary products firm Dechra Pharmaceuticals PLC on Wednesday said it is planning a fundraise for an acquisition, as it progresses talks for another potential buy.

Read more
14 Jul 2022 08:29

IN BRIEF: Dechra diversifies funding with private placement notes

Dechra Pharmaceuticals PLC - veterinary products firm - Signs private placement of EUR50 million seven year and EUR100 million ten year senior unsecured notes. Weighted average coupon of the fixed rate notes will equate to 3.8%. Says issue has similar covenants to existing facilities. "The private placement is being undertaken now to achieve the group's aim of ensuring diversified sources of funding and to extend the group's debt maturity profile. All proceeds from the placement will be used to repay existing debt on the group's revolving credit facility." Dechra says.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.